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To ﬁnd the regulatory pathways of DNp63a, we assessed whether DNp63a is acetylated and deter-
mined the functional implications of acetylation. First, the hinge region of p63 was shown to be acet-
ylated by PCAF, similarly to other p53 family members. Second, acetylation synergistically induced
cytoplasmic localization of DNp63a. Finally, acetyl-DNp63a was induced during high-density cul-
ture, suggesting that acetylation of DNp63a may reinforce cell cycle arrest upon cell contact. Alto-
gether, these ﬁndings suggest that acetylation of DNp63a contributes to the epidermal homeostasis.
Structured summary of protein interactions:
PCAF acetylates DNp63a by acetylation assay (View Interaction: 1, 2, 3)
DNp63a physically interacts with DNp63a by anti tag coimmunoprecipitation (View interaction)
DNp63a physically interacts with p53 by anti bait coimmunoprecipitation (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
p63, an ancient homolog of p53, is indispensable for the main-
tenance of stratiﬁed epithelia [1–3]. Recent ﬁndings suggest that
p63 is involved in protection against metastasis [4,5] and in main-
tenance of the genomic integrity of female germ cells [6]. The
pleiotropic functions of p63 are performed by distinct forms of
p63. DNp63a is an isoform predominantly expressed in epidermal
stem cells and cancer. DNp63a antagonizes p53 and maintains
proliferative capacity of epidermal stem cells and progenitors [7–
9]. On the other hand, TAp63a is the only form expressed in the
female germ cells and activates death program upon genotoxic in-
sults [6].
Although the developmental role of p63 is well deﬁned, its
involvement in cancer has remained elusive. Unlike p53, mice
heterozygous for the gene encoding p63 do not show overt tu-
mor-susceptibility, and p63 mutations are rarely found in human
cancer [10,11]. In contrary, DNp63a is frequently over-expressed
in squamous cell carcinomas and other cancers [12–15]. Recent
whole exome sequencing identiﬁed a p63 mutation in head and
neck squamous cell carcinoma as well [16]. In addition, p63 deﬁ-
ciency activated cellular senescence [17], and the expression of
DNp63a inhibited oncogene-induced senescence and cooperatedchemical Societies. Published by E
gmail.com (H. Lee).with the oncogenic Ras in tumor promotion [18]. These ﬁndings
suggest that DNp63a might contribute to tumorigenesis at an
early stage. Furthermore, depletion of DNp63a sensitized cancer
cells to genotoxic drugs [19,20], suggesting that regulation of
DNp63a expression may likely be a matter of life and death for
normal as well as cancer cells.
The epidermal stem cell-speciﬁc expression of DNp63a is ﬁrst
induced at the transcription level, and the stem cell-speciﬁc tran-
scriptional elements are being partially characterized [21,22].
P63 protein also undergoes extensive post-translational modiﬁca-
tions, which regulate its stability and function. Phosphorylation
and sumoylation of p63 have been linked to both its activation
and degradation [23–25]. The concept of post-translational modiﬁ-
cations is not unfamiliar in this protein family. For instance, p53,
upon genotoxic stress, becomes stabilized and subjected to multi-
ple post-translational modiﬁcations including phosphorylation and
acetylation. The acetylation event is absolutely required for p53 to
exert its transcription activation [26,27]. It is conceivable that p63
may also be acetylated, given that p53 and p63 share many regu-
latory pathways.
In this study, we assessed whether p63 is acetylated and iden-
tiﬁed two acetylation sites in the hinge region. The biochemical
properties of acetylation mimic form of DNp63a revealed that
acetylations promote cytoplasmic localization of DNp63a. In addi-
tion, by generating acetyl-p63 speciﬁc antibodies, we found that
acetylations occur when cells were grown to high density for bothlsevier B.V. All rights reserved.
AcK 
GST 
Δ1
+- - + +-
BA
AcK
WTΔ2
+- - + +-
K267RK259R
- + +
WTK275R
+
Δ2 Δ3 Δ2
PCAF]
GST-ΔNp63α
PCAF
acetyl-CoA ++ + + ++ -
∗
C D
++ + + ++ -
K281R K298RK297R
K281R
K297R
K322R
K324R
++
+- - + +- - + +
++ + + ++ ++
-
++
PCAF
acetyl-CoA
∗
E
F p63 (ΔNp63α)
p73
p53
DNA binding Oligomerization SAM Tc inhibition
88                      263     299                    329      439                     501                     586
Acetylation
DG T K R P F RQN T HG I QM T - - S I KKRRD S AK N G 300272
G S T K R A L S N N T S S S P Q P - - - - - K K KHH E L P P 321296
A A S K R A F KQ S P P A V P A L GAG V KKRRS S AK N G 348318
GST 
Fig. 1. Hinge region of p63 is acetylated by PCAF. (A) In vitro acetylation was performed on DNp63a fragments; D1 (aa. 88–184), D2 (aa. 256–348), and D3 (aa.343–586).
Western blotting (WB) by anti-acetyl Lys (AcK) Ab shows D2 fragment, located between the DNA binding and oligomerization domain, is robustly acetylated (arrow). Weak
acetylation was also detected on the D1 and C-terminal D3 fragments (asterisks). (B) In vitro acetylation was performed on DNp63a fragments with [1-14C] acetyl-CoA and
detected by autoradiogram. (C) Lysines in the D2 fragment were substituted with arginine as indicated and in vitro acetylations were carried out. Western blotting with anti-
AcK Ab shows acetylation was decreased in the K281R and K297R single substitution mutants and completely absent in the double substitution K281RK297R mutant. (D) In
vitro acetylation was performed on D2 mutants with [1-14C] acetyl-CoA and detected by autoradiogram. (E) A diagram showing acetylation sites of DNp63a on the hinge
region, K281 and K297. (F) Alignment of human p53, p63, and p73 sequences around K281 and K297 by Vector NTI software (Invitrogen). P63 sequences are numbered as in
DNp63a. Lysines marked by bold K characters are known acetylation sites. K320 in p53 could be aligned to K297 of DNp63a.
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results suggest that acetylation of DNp63a is a regulatory mecha-
nism that modulates cell growth and maintains epidermal
homeostasis.
2. Materials and methods
2.1. Cell culture
ME180 cells (ATCC, Manassas, VA) were maintained in RPMI-
1640 supplemented with 10% v/v fetal bovine serum and antibiot-
ics (Hyclone, Logan, UT). Saos-2 (ATCC) and 293T cells (Invitrogen,
Carlsbad, CA) were cultured in DMEM supplemented with 10% v/v
fetal bovine serum and antibiotics. Human epidermal keratino-
cytes were cultured in KGM-gold media (Lonza, Switzerland). Cells
were split at 1  106 per 10 cm culture dish unless stated
otherwise.
2.2. DNA constructs and antibodies
pcDNA 3.myc-DNp63a and pcDNA 3.myc-p53 were kind gifts
from F. Mckeon (Harvard Medical School, MA). GFP-DNp63a was
subcloned from pcDNA3.myc-DNp63a into pEGFP C1 (Invitrogen)
and p63 deletion constructs were subcloned into pGEX 4T-2 (GE
healthcare, Piscataway, NJ). To generate arginine or glutamine sub-
stitution mutants, site-directed mutagenesis was performed using
npfu forte (Biostream, Korea).Ac-p63 speciﬁc antibodies were obtained by immunization of
rabbits with chemically acetylated p63 peptide Ac-
K281[KNGDGT(AcK)RPFR] or Ac-K297 [QMTSI(AcK)KRRS-C]
(AbFrontier, Korea). The collected sera were afﬁnity puriﬁed on
immobilized acetylated peptides after removal of antibodies recog-
nizing unacetylated p63. Monoclonal anti-p63 (4A4) and anti-Myc
(9E10) Abs were from F. Mckeon. The following commercial anti-
bodies were utilized: anti-acetyl lysine (4G12 mouse monoclonal,
Millipore, Billerica, MA); anti-acetyl lysine (Rabbit polyclonal),
anti-p53 pSer15, anti-ab tubulin, and anti-Lamin A/C Abs from Cell
Signaling (Danvers, MA); anti-p53 (clone DO-1) from Oncogene
Science (Cambridge, MA); anti-p21, anti-b-actin, and anti-GFP
(mouse monoclonal) Abs from Santa Cruz (Santa Cruz, CA).
2.3. siRNA and DNA transfection
siRNA and DNA plasmids were transfected using Lipofect-
amine2000 (Invitrogen) according to the manufacturer’s protocol.
siRNA (Bioneer, Korea) target sequences are as follows. Luciferase,
CGUACGCGGAAUACUUCGGAdTdT; p63, CCUAGUCAUUUGAUUC-
GAGUAdTdT; p53, AAGACUCCAGUGGUAAUCU ACdTdT.
2.4. Protein puriﬁcation and in vitro acetylation assay
GST-fused DNp63a deletion fragments and GST-PCAF HAT do-
main (amino acids 352–832) were puriﬁed from Escherichia coli
by glutathione 4 Sepharose fast ﬂow beads (GE healthcare). In vitro
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Fig. 2. DNp63a acetylation mimic mutants are preferentially localized in the cytoplasm. (A) Saos-2 cells were transfected with GFP-tagged wild type, acetylation-defective,
and acetylation-mimic DNp63a. Wild type and acetylation-deﬁcient mutants are mainly in the nucleus whereas acetylation-mimic mutants show both nuclear and
cytoplasmic localization. GFP signals were analyzed in 60–80 cells per each group and the percent of cells showing cytoplasmic DNp63a is indicated in the parentheses.
Experiments were repeated three times. (B) Phosphorylation of WT and mutant DNp63a were visualized by slow migration in the polyacrylamide gel and treatment with
lambda phosphatase. Sumoylation defective mutant K582R was used as a heavily phosphorylated control. (C) p63–p63 or p63–p53 interaction was assessed by transfection in
293T cells followed by co-immunoprecipitation.
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fragments using active PCAF for 1 h at 30 C in HAT buffer
(250 mM Tris–HCl [pH 8.0], 50% glycerol, 0.5 mM EDTA, 5 mM
DTT, and 1 mM unlabeled acetyl-coA). Proteins were separated
by SDS–PAGE and analyzed by Western blot using anti-acetyl ly-
sine antibodies. For detection by autoradiogram, in vitro acetyla-
tion assay was performed using 0.05 lCi of [1-14C] acetyl-CoA
(GE healthcare) and signals detected by BAS2500 phosphor Imager
(Fujiﬁlm, Japan).
2.5. Cytoplasmic fractionation
We followed the protocols by Wysocka et al. [28]. Brieﬂy, cells
were harvested in cold PBS and lysed in (10 mM HEPES [pH7.9],
10 mM KCl, 1.5 mM MgCl2, 0.34 M Sucrose, 10% glycerol, 1 mM
DTT, and 0.1% Triton X-100). The supernatant was collected as
the cytoplasmic fraction and pellets were further lysed in 3 mM
EDTA, 0.2 mM EGTA, and 1 mMDTT. The supernatant was collected
as the nuclear soluble fraction and pellets were boiled in SDS sam-
ple buffer as the chromatin/nuclear matrix associated fraction. Pro-
tease inhibitors (1 mM phenylmethanesulfonyl ﬂuoride, 1 lg/mlaprotinin, 1 lg/ml pepstatin A, 2 lg/ml Na3VO4, 1 lg/ml leupeptin,
10 mM N-ethylmaleimide) were added to all the lysis solutions.
Chemicals were from Sigma (St. Louis, MO).
2.6. Western blot and Immunoprecipitation
Cells were lysed in NETN buffer (150 mM NaCl, 1 mM EDTA,
20 mM Tris [pH 8.0], 0.5% NP-40) supplemented with protease
inhibitors. Immunoprecipitation was carried out with 2–4 mg of
cell lysates using anti-p63 or anti-Myc antibody and protein A/G
beads (Sigma). For direct Western blot analysis, 50–100 lg of cell
lysates were loaded and probed with appropriate antibodies.
2.7. RT-PCR
RNA was isolated by Trizol reagent (Invitrogen), and 5 lg RNA
was reverse transcribed by Superscript II (Invitrogen) in a 20 ll
reaction. For each PCR, 1 ll cDNA was utilized using following
primers. p21 forward, AAGACCATGTGGACCTGT; p21 reverse,
GGTAGAAATCTGTCATGCTG; p27 forward, GTGCGAGA GAG-
GCGGTCGTG; p27 reverse, TCCACCGGGCCGAAGAGGTT; 14-3-3r
Y.-S. Chae et al. / FEBS Letters 586 (2012) 1128–1134 1131forward, AGAGCTGAGGCCACCTGGGG; 14-3-3r reverse,
CGGTCTTGCACTGGCGCGC; Bax forward, TGACATGTTTTCTGACGG-
CAAC; Bax reverse, GGAGGCTTGAGGAGTCTCACC; Noxa forward,
GAGATGCCTGGGAAGAAGG; Noxa reverse, ACGTGCACCTCCTGA-
GAAAA; GAPDH forward, GAAGGTGAAGGTCGGAGTC; GAPDH
reverse, GAAGATGGTGATGGGATTT.
For real time detection, PCR reactions were ran on the One Step
system (Applied Biosystems, Foster City, CA) using p21 or GAPDH
primers in combination with SyBr (Applied Biosystems).
2.8. Flowcytometry
For the assessment of cell cycle proﬁle, single-cell suspensions
were ﬁxed in 70% EtOH and stained with Propidium Iodide. Cells
were analyzed by FACSCanto (Beckton Dickinson) using FACSDiva
software.
2.9. Image analysis
For the detection of GFP-DNp63a, Saos-2 cells were transfected
with WT or mutant construct, and ﬁxed in 4% paraformaldehyde
48 h later. Slides were mounted in Vectashield mounting medium
with DAPI (Vector Lab, Burlingame, CA) and analyzed on the Axio-
vert inverted microscope with a 40 oil lens (Carl Zeiss, Germany).
Phase contrast images were photographed on the Axiovert
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3.1. Identiﬁcation of acetylation sites for p63
In order to assess the acetylation of DNp63a, we performed an
in vitro acetylation assay with puriﬁed proteins. We generated
GST-tagged deletion constructs of DNp63a and set up acetylation
reactions using PCAF as the acetyl transferase (Fig. 1A). We de-
tected a strong signal for acetyl-lysine on the D2 fragment, con-
taining 30 regions post DNA-binding domain and the whole
oligomerization domain. By comparison, there was only a weak
signal for acetyl-lysine on the D1 and D3 fragments. We also per-
formed an acetylation assay using [1-14C]-labeled acetyl-CoA and
conﬁrmed our results by autoradiogram (Fig. 1C). The robustly-
acetylated D2 fragment contained 8 lysine residues, in which we
mutated a single lysine (K) to arginine (R) and performed an
in vitro acetylation assay. We found that K281R and K297R mu-
tants were compromised in their acetylation, and double acetyla-
tion mutant K281R297R was not acetylated at all (Fig. 1B).
Arginine mutants for other lysines (K259R, K267R, K275R, K298R,
K322RK324R) showed similar level of acetylation to the wild type
(WT). 14C autoradiography conﬁrmed our results (Fig. 1D).
Together, these results identiﬁed two acetylation sites of DNp63a
localized in the hinge region between the DNA binding and oligo-
merization domain (Fig. 1E). Both lysines are conserved in other
p53 family members (Fig. 1F).GST
PCAF
p63
]
Fig. 3. Generation of acetyl-p63 antibodies to the K281 and K297 sites. Rabbit
polyclonal antibodies were generated to the acetylated p63 peptides spanning Ac-
K281 or Ac-K297, and afﬁnity puriﬁed. (A) Anti-AcK281 Ab detects only acetylated
D2 fragments, not unacetylated fragment or K281R mutant. Anti-AcK297 Ab detects
only acetylated D2 fragments, not unacetylated fragment or K297R mutant. Anti-
AcK281 Ab shows slight cross reactivity to PCAF. Blots were also detected by anti-
AcK Ab to show acetylation status and anti-GST Ab for the protein loading control.
(B) ME180 cells were transfected with siRNA against p63 and WB performed with
anti-AcK281 or AcK297 Abs. Signals for the Ac-K281 and Ac-K297 disappear after
p63 silencing, verifying the Ab speciﬁcity.3.2. Analysis of acetylation-defective or mimic mutant DNp63a
To gain insights on the function of acetylation, we ﬁrst charac-
terized the acetylation-defective arginine or acetylation-mimic
glutamine (Q) substitution mutants of DNp63a. We expressed
the WT or mutant DNp63a and analyzed their expression pattern
in Saos2 cells. As shown in Fig. 2A, GFP-tagged WTDNp63a is
mainly localized in the nucleus, as are the acetylation-defective
mutants. By comparison, acetylation-mimic mutants showed both
nuclear and diffuse cytoplasmic localization. In particular, a larger
proportion of K281QK297Q double acetylation-mimic mutant wascytoplasmic. These data suggest that dual-acetylation on the two
sites may cooperate for the nuclear export of DNp63a. Interest-
ingly, the K281QK297Q mutant showed a low degree of phosphor-
ylation compared to the WT and other mutants (Fig. 2B). As the
phosphorylation could affect multimerization for p63 [29], we
determined whether acetylation mutants possessed different abil-
ity to form a homotypic or heterotypic complex with p53 (Fig. 2C).
However, WT and all the mutantDNp63a’s were able to form p63–
p63 and p63–p53 complexes, indicating that acetylation on the
hinge region did not affect oligomerization between the family
members.
3.3. DNp63a acetylation in high-density cell culture
Next, to determine whether acetylations on K281 and K297
sites occur in vivo and if so, to deﬁne the physiologic role, we gen-
erated acetyl-p63 speciﬁc antibodies on these sites. The rabbit
polyclonal antibodies exclusively detected acetylated K281 (Ac-
K281) or K297 (Ac-K297) for in vitro acetylated p63 fragments
(Fig. 3A). Using these antibodies, we determined the presence of
acetylated p63 in ME180 cervical cancer cells and detected low
levels of K281 and K297 acetylation, veriﬁed by siRNA for p63
(Fig. 3B). Then in search of conditions where DNp63a acetylation
might be stimulated, we found that acetylations increase when
cells are grown to higher conﬂuency by increased plating cell num-
ber (Fig. 4A and B) or by increased culture time (Fig. 4C and D).
Acetylation was more profound for the K297 site, and the timing
of acetylation on K281 preceded that on K297 site (Fig. 4C). This
suggests that p63 acetylations might occur sequentially in re-
sponse to cell contact. Acetylation on K281 and K297 sites did
not increase in response to DNA damage inﬂicted by gamma irra-
diation or high-dose UV irradiation (data not shown). The overall
increase ofDNp63a acetylation in conﬂuent culture was conﬁrmed
by detection of acetyl lysine after p63 immunoprecipitation as well
(Fig. 4E). In this condition, p53 was modestly phosphorylated and
stabilized (Fig. 4A and C), indicating transient activation of the
1132 Y.-S. Chae et al. / FEBS Letters 586 (2012) 1128–1134p53 pathway. Concomitantly, the cell cycle inhibitor p21 was
upregulated. In the conﬂuent culture condition, the upregulation
of p21 could be ascribed to p53 activity, as silencing p53 blocked
p21 induction (Fig. 4F). On the other hand, silencing p63 further
upregulated p21 levels, suggesting that repression of DNp63a con-
tributed to the induction of p21.
To further investigate the factors responsible for the density-
dependent growth inhibition, we assessed mRNA levels of p21
and other cell cycle inhibitory genes (Fig. 5). Among these, induc-
tion of p21 was substantial, although we failed to detect upregula-
tion of others including p27 and 14-3-3r. We also checked mRNA
levels for pro-apoptotic p53 target genes but did not ﬁnd any differ-
ences. The fold-induction of p21 mRNA was assessed by real time
PCR to be 4–6 foldwhen cells reached to >90% conﬂuency compared
to the low density culture (30% conﬂuent) condition (Fig. 5A and B).A
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The density-dependent induction of p21 can be ascribed to the
activation and stabilization of p53 (Fig. 4F). It is also possible that
DNp63a is modiﬁed in such a way to lose the ability to repress
p21. In Fig. 2A, we demonstrated that acetylation-mimic mutants
of DNp63a are more preferentially localized to the cytoplasm.
Therefore, we assessed whether DNp63a, upon high cell density,
can be acetylated and localized in the cytoplasm. To do this, we
harvested cells at low or high density, and separated them into
cytoplasmic, nuclear soluble, and chromatin/nuclear matrix- asso-
ciated fractions. As shown in Fig. 6A, a high proportion of DNp63a
was associated with chromatin or nuclear matrix for low density
cells. By comparison, the chromatin/nuclear matrix-bound fraction%
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Y.-S. Chae et al. / FEBS Letters 586 (2012) 1128–1134 1133signiﬁcantly decreased in conﬂuent cells, whereas the cytoplasmic
fraction increased. Interestingly, Ac-K281-DNp63a was predomi-
nantly found in the nuclear soluble fraction, whereas Ac-K297-
DNp63a was mostly cytoplasmic. These data link K281 and K297
acetylations to the nuclear export signal and also suggest that acet-
ylations on K281 and K297 sites may occur in a sequential manner.
Importantly, K281 and K297 acetylations were also induced in
normal keratinocytes in high-density culture conditions (Fig. 6B),
suggesting that normal epidermal compartment might utilize
p63 acetylation to modulate cell growth. Taken together, acetyla-
tion of DNp63a could be a homeostatic mechanism by which cells
regulate their proliferative rate without permanent commitment.
4. Discussion
Regulation of cell growth is fundamental in the development
and homeostasis of multicellular organisms, and any alteration
may lead to serious diseases including cancer. P63 is a p53 homo-
log whose expression as a DNp63a form is restricted to the epider-
mal stem cell compartment and essential for the proliferative24
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were fractionated into cytoplasmic [C], nuclear soluble [NS], and nuclear matrix/chromati
K297-DNp63a are increased at high cell density. Cell fractionation was monitored by cyt
or 3  106 cells per 10 cm dish for 24 h and fractionated as in (A).potential [9]. Therefore, the absence of DNp63a results in develop-
mental defects in the epidermis and all the derivatives [3]. The lack
of DNp63a also causes cellular senescence and premature aging
[17], and DNp63a has been recently implicated in the bypass
mechanism of cellular senescence in oncogene-induced transfor-
mation [18]. In this study, we provide a new set of evidence linking
acetylation of DNp63a to density-dependent inhibition of cellular
proliferation as a homeostatic mechanism.
DNp63a in the stratiﬁed epithelia controls the proliferative
capacity of stem cells and progenitors [9]. This function is well-
supported by the ﬁnding that p63-deﬁcient mice exhibit a malfor-
mation of stratiﬁed epithelia attributed to the failure in the main-
tenance of stem and progenitor cell populations [3]. In addition,
overexpression of DNp63a induces epidermal hyperplasia [30],
further strengthening the association between DNp63a expression
and proliferative capacity. The association is also evident for the
studies by Pellegrini on the isolated corneal epithelium [31]. Holo-
clones isolated from the basal cells of the limbal epithelium ex-
press high levels of DNp63a and retain high proliferative
capacity as well as the potential to form complete epithelial layers
in culture. By comparison, paraclones no longer express DNp63a
and terminally differentiate after a few rounds of cell division.
Meroclones express low to moderate levels of DNp63a and possess
higher levels of proliferative capacity than paraclones. These char-
acteristics of corneal epithelial cells indicate that the level of
DNp63a determines the proliferative potential of cells at a distinct
differentiation stage. In comparison, acetylation of DNp63a seems
to be a reversible mechanism to control the rate of cell prolifera-
tion within a compartment. In order to maintain homeostasis, pro-
liferating cells need to accommodate environmental stimuli and
adjust cell cycle progression accordingly. High cell density would
transcend an environmental cue to induce DNp63a acetylation
and p53 activation. These changes stimulate the expression of
the cell cycle arrest gene p21 and hence slow down cell prolifera-
tion. The transient and reversible growth inhibition will eventually
help cell survival.
In the conﬂuent cell culture condition, p21 was the only abun-
dantly induced p53 target. The basis for this has been suggested by
others that low levels of p53 might induce genes with a high afﬁn-
ity for p53 binding, which are genes related to the cell cycle arrest
but not apoptosis [32]. ME180 cells are known to harbor HPV se-
quences [33], and therefore their p53 was thought to be non-func-
tional. However, in our study we were able to show that the p53
function is somewhat preserved, and that it could induce transcrip-
tion of p21. It may be true that the available p53 in these cells are
low, that the cell cycle arrest genes are preferentially induced in
these cells. Additionally, we found that HaCaT cells, an72 h
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did not upregulate p21 in the conﬂuent culture condition (Lee,
unpublished data). By comparison, normal keratinocytes moder-
ately upregulated p21 (Lee, unpublished data), suggesting that
p53 and acetyl-DNp63a inter-dependently regulate cell cycle
progression for normal epidermal cells. Therefore, acetylation of
DNp63a is a mechanism that leads to skewing cellular responses
towards cell cycle arrest instead of permanent cell death.
In our study, we did not pursue the acetylation of C-terminal
fragment of p63 because our assay demonstrated much weaker
acetylation on the C-terminus compared to the mid-region. How-
ever, this could have been due to the limitations of our assay and
further investigation is necessary to completely delineate the acet-
ylation map of DNp63a. For p53, acetylation on the hinge region
(K320, may be equivalent to K297 of DNp63a) by PCAF, and heavy
acetylation on the C-terminal region as well as the DNA binding
region by CBP have been reported [27,35,36]. Acetylation-defective
p53 mutant on the DNA binding and C-terminal region failed to
activate the p21 gene [27]. By comparison, acetylation on the hinge
region negatively regulated the pro-apoptotic activity of p53 [37].
For p73, acetylation on the hinge region was mediated by p300 and
was responsible for the DNA damage-dependent induction of
apoptotic targets [38]. For p63, p300 acetylated and induced the
transcription targets of TAp63c isoform, yet the acetylation sites
were not deﬁned [39]. In the present study, we identiﬁed two acet-
ylation sites in DNp63a and related them to the cell density-
dependent growth inhibition. We also found that acetylation of
DNp63a can be enhanced by CBP or less by p300 in cultured cell
lines (Lee, unpublished data). The CBP/p300-derived acetylation
was not affected by arginine substitution of K281 or K297, indicat-
ing that additional acetylation sites may exist. These sites may
reside in the N-or C-terminal p63 and correspond to the p300-
mediated acetylation sites described by MacPartlin et al. [39].
Therefore, in line with our hypothesis, acetylation of p63 appears
to be tightly linked to its function, similar to p53, and levels of
complexity exist. Further investigation is warranted.
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